Loperamide (hydrochloride)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Loperamide (hydrochloride)
Description :
Loperamide (hydrochloride) (R-18553 (hydrochloride) ) is an opioid receptor agonist[1][2][3]. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect[4].Product Name Alternative :
R-18553 (hydrochloride)UNSPSC :
12352005Hazard Statement :
H301Target :
Autophagy; Opioid ReceptorType :
Reference compoundRelated Pathways :
Autophagy; GPCR/G Protein; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Metabolic Disease; Neurological Disease; CancerAssay Protocol :
https://www.medchemexpress.com/Loperamide-hydrochloride.htmlConcentration :
10mMPurity :
99.89Solubility :
DMSO : 43.75 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 1 mg/mL (ultrasonic)Smiles :
O=C(N(C)C)C(C1=CC=CC=C1)(C2=CC=CC=C2)CCN3CCC(O)(C4=CC=C(Cl)C=C4)CC3.ClMolecular Formula :
C29H34Cl2N2O2Molecular Weight :
513.50Precautions :
H301References & Citations :
[1]Hanauer, S.B., The role of loperamide in gastrointestinal disorders. Rev Gastroenterol Disord, 2008. 8 (1) : p. 15-20.|[2]Litovitz, T., et al., Surveillance of loperamide ingestions: an analysis of 216 poison center reports. J Toxicol Clin Toxicol, 1997. 35 (1) : p. 11-9.|[3]http://www.drugs.com/mmx/loperamide-hydrochloride.html|[4]Hatfield MJ, et al. Carboxylesterase inhibitors. Expert Opin Ther Pat. 2011 Aug;21 (8) :1159-71.|[5]Svenja Zielke, et al. ATF4 links ER stress with reticulophagy in glioblastoma cells. Autophagy. 2021, 17, 9.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture)Scientific Category :
Reference compound1Clinical Information :
LaunchedCitation 01 :
Cell Rep Methods. 2023 Oct 23;3 (10) :100599.|Dig Dis Sci. 2025 Nov 15.|eFood. 2025 Jul 14.|Food Qual Saf. 2024 Sep 10.|J Appl Microbiol. 2023 Aug 1;134 (8) :lxad153.|J Transl Med. 2021 Jul 23;19 (1) :317.|Viruses. 2021 Jun 28;13 (7) :1255.|Curr Med Sci. 2025 Aug 29.|Nature. 2025 Dec;648 (8094) :755-763.|Oncol Rep. 2025 Oct;54 (4) :133.|Phytomedicine. 2025 Oct 16:148:157417.CAS Number :
[34552-83-5]

